Bilateral Conjunctivitis

Differentiating between infectious and non-infectious bilateral conjunctivitis in adults requires a systematic approach. Start by assessing the character of the discharge (watery, mucoid, purulent). Purulent discharge suggests bacterial conjunctivitis, while watery discharge is more common in viral or allergic conjunctivitis. Itching is a hallmark of allergic conjunctivitis, whereas pain may indicate a more serious condition like iritis or keratitis. Preauricular lymphadenopathy is often present in viral conjunctivitis but less so in bacterial or allergic forms. Consider patient history, including contact lens use, recent upper respiratory infection, and allergy history. Explore how to incorporate point-of-care testing, like rapid adenoviral antigen detection, to aid in diagnosis and guide appropriate management. For atypical presentations or lack of response to initial therapy, consider implementing ophthalmological referral for further evaluation and specialized testing like corneal cultures.

Distinguishing viral from bacterial bilateral conjunctivitis in children can be challenging due to overlapping symptoms. Viral conjunctivitis typically presents with watery or mucoid discharge, often accompanied by preauricular lymphadenopathy and symptoms of an upper respiratory infection. Bacterial conjunctivitis, on the other hand, often presents with purulent discharge, matting of the eyelids, and less prominent systemic symptoms. Evidence-based treatment for bacterial conjunctivitis typically involves topical antibiotic drops or ointment, such as erythromycin or polymyxin/trimethoprim. Viral conjunctivitis is generally self-limiting, with treatment focused on supportive care, such as cool compresses and artificial tears. However, consider implementing antiviral medications for severe cases or those caused by herpes simplex virus. Learn more about the appropriate use of antibiotics in conjunctivitis to avoid antibiotic resistance. In cases of uncertainty or severe symptoms, prompt ophthalmological referral is recommended.

Managing allergic bilateral conjunctivitis in patients with atopic dermatitis or other allergic conditions requires a multifaceted approach addressing both ocular and systemic allergy control. Non-pharmacological interventions include allergen avoidance, cool compresses, and lubricating eye drops. Pharmacological options include topical antihistamines, mast cell stabilizers, and dual-action agents that combine both mechanisms. For more severe cases, topical corticosteroids may be considered under the supervision of an ophthalmologist. In patients with concurrent atopic dermatitis, optimizing management of the underlying skin condition can also improve ocular symptoms. Explore how systemic antihistamines or immunomodulatory therapies may be beneficial in patients with severe or refractory allergic conjunctivitis. Consider implementing a collaborative care approach involving allergists, dermatologists, and ophthalmologists for comprehensive patient management.